ACW vs PYC

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

ACW

ACTINOGEN FPO [ACW]

49LOW

PYC

PYC THERAP FPO [PYC]

53MEDIUM

Score Breakdown

ACW PYC
Technical
76
60
Catalyst
55
55
Sentiment
50
50
Fundamental
39
42
Momentum
57
75
Risk Gate
45
50

Key Metrics

ACW Metric PYC
$167.3MMarket Cap$1.5B
4.3MAvg Volume (20d)1.1M
N/AShort Interest+0.3%
$0.07252-Week High$1.755
$0.02352-Week Low$0.848
-2.3%Daily Change-1.3%
$0.043Reference Price$1.530
-110.8%ROE-47.5%
-243.2%Profit Margin-231.3%

Active Signals

ACW Signals

Golden cross just fired — the short-term trend is overtaking the long-term, which is classically bullish
Above-average volume (1.6x) on a red day — sellers in control
On a tear — up 13.2% over the last 5 days
Beating the Small Ords index — relative strength of 1.44, so it's outpacing the pack
Trading above the 200-day average — the long-term trend is on your side
Critical cash runway (1.6 quarters)
Piotroski F-Score weak (3/9, low-confidence approx)
Director buying detected (1 transactions)

PYC Signals

MACD momentum is losing steam
Bollinger Bands are tightening — volatility is coiling up for a potential breakout
Beating the Small Ords index — relative strength of 1.23, so it's outpacing the pack
Trading above the 200-day average — the long-term trend is on your side
Adequate cash runway (7 quarters)
Very high P/S ratio (74.1x)
Revenue in sharp decline (-25%)
Piotroski F-Score weak (3/9, low-confidence approx)

Ask Scout AI to compare ACW and PYC in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

ACW vs TRI →AGN vs BIT →AGN vs CBL →AGN vs ECS →AGN vs IBX →
ACW Full Analysis → PYC Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).